ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,683.00
-0.01%
S&P ASX All Technology
3,008.10
0.02%
Brent Oil
87.105
-0.13%
US Dollar vs AUD
1.53178
-0.48%
Bitcoin
63,927.35
-0.55%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aileron Therapeutics Inc (ALRN)

  7. Aileron Therapeutics Inc (ALRN) News

ALRN Aileron Therapeutics Inc

4.93
0.00 (0.00%)
Pre Market
Last Updated: 18:42:25
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aileron Therapeutics Inc ALRN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 4.93 18:42:25
Open Price Low Price High Price Close Price Previous Close
4.93
more quote information »

Recent News

Date Time Source Heading
16/4/202407:20GLOBEAileron Therapeutics Reports Fourth Quarter and Full Year..
12/3/202423:00GLOBEAileron Therapeutics Announces CEO Transition
07/3/202409:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:01EDGAR2Form 8-K - Current report
16/2/202408:05GLOBEAileron Therapeutics and Pulmonary Care Experts To Discuss..
13/2/202423:01EDGAR2Form 8-K - Current report
06/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
06/2/202405:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/2/202408:30GLOBEAileron Therapeutics to Host Key Opinion Leader Event on..
01/2/202408:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/1/202408:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/1/202408:10EDGAR2Form S-3 - Registration statement under Securities Act of..
30/1/202400:46EDGAR2Form DEF 14A - Other definitive proxy statements
30/1/202400:14EDGAR2Form 8-K - Current report
25/1/202423:00EDGAR2Form 8-K - Current report
20/1/202408:44EDGAR2Form PRE 14A - Other preliminary proxy statements
12/1/202408:18EDGAR2Form 8-K/A - Current report: [Amend]
11/1/202408:08EDGAR2Form 8-K - Current report
19/12/202309:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202308:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202309:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/11/202311:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202311:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/11/202311:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/11/202303:40EDGAR2Form 8-K - Current report
01/11/202303:30PRNUSAileron Therapeutics Announces Acquisition of Lung..
14/10/202307:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/8/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Your Recent History

NASDAQ
ALRN
Aileron Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved